For patients with needle phobia or strong preferences for oral GLP-1 medication, compounded tirzepatide tablets offer an alternative worth considering with appropriate counseling about the differences in evidence
The FDA said in October that it had received multiple reports of adverse events, some requiring hospitalization, that may be related to dosing errors associated with compounded injectable semaglutide products. The agency also warned that some compounders may be selling salt forms of semaglutide, which are different active ingredients than are in the approved drugs, and that counterfeit forms of Ozempic are being sold
"List: Who won People's Choice Awards?"
CONTRIBUTING EXPERT Sinikka Green, MD Dr
Semaglutide, marketed under the brand names Ozempic, Wegovy, and Rybelsus, is a GLP-1 agonist available in various forms, including weekly injections (Ozempic for diabetes and Wegovy for obesity) and daily oral tablets (Rybelsus)
Combine with Fiber: Eat a diet rich in vegetables and whole grains